CIK: 1709113 - Address: C/o Celldex Therapeutics, Inc., 53 Frontage Road, Suite 220, Hampton, NJ 08827
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
6/3/24 16:04
5/30/24
CLDXCelldex Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticCavanaugh SarahNJOSVP of CM.d1215.800212D
6/3/24 16:04
5/30/24
CLDXCelldex Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticCavanaugh SarahNJOSVP of CS.d-70333.730-21-922D
8/19/22 16:06
8/17/22
CLDXCelldex Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticCavanaugh SarahNJOSVP of CM.dm993.040331D
8/19/22 16:06
8/17/22
CLDXCelldex Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticCavanaugh SarahNJOSVP of CS.dm-1,20036.720-33-961D
12/10/21 16:03
12/8/21
CLDXCelldex Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticCavanaugh SarahNJOSVP of CM.d7310.03070D
12/10/21 16:03
12/8/21
CLDXCelldex Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticCavanaugh SarahNJOSVP of CS.d-29340.000-7-950D
11/3/21 16:02
11/1/21
CLDXCelldex Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticCavanaugh SarahNJOSVP of CM.d488.03060D
11/3/21 16:02
11/1/21
CLDXCelldex Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticCavanaugh SarahNJOSVP of CS.d-31743.260-7-950D
6/11/20 07:54
6/10/20
CLDXCelldex Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticCavanaugh SarahNJOSVP of CP54.83013311D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact